PortfoliosLab logoPortfoliosLab logo
NBIS vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NBIS vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nebius Group N.V. (NBIS) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NBIS achieves a 159.15% return, which is significantly higher than NVO's 0.44% return.


NBIS

1D
18.78%
1M
-24.34%
6M
118.47%
YTD
159.15%
1Y
314.21%
3Y*
5Y*
10Y*
ALL TIME*
301.22%

NVO

1D
-0.46%
1M
14.33%
6M
-15.78%
YTD
0.44%
1Y
-20.39%
3Y*
-13.64%
5Y*
4.47%
10Y*
8.13%
ALL TIME*
14.50%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NBIS vs. NVO - Yearly Performance Comparison


2026 (YTD)20252024
NBIS
Nebius Group N.V.
159.15%202.18%46.25%
NVO
Novo Nordisk A/S
0.44%-39.22%-27.24%

Correlation

The correlation between NBIS and NVO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Oct 18, 2024

0.14

Fundamentals

Market Cap

NBIS:

$52.06B

NVO:

$219.43B

EPS

NBIS:

$3.08

NVO:

DKK 27.42

PE Ratio

NBIS:

70.35

NVO:

11.79

PEG Ratio

NBIS:

24.17

NVO:

0.51

PS Ratio

NBIS:

67.03

NVO:

4.39

PB Ratio

NBIS:

9.26

NVO:

7.08

Total Revenue (TTM)

NBIS:

$877.90M

NVO:

DKK 327.80B

Gross Profit (TTM)

NBIS:

$420.60M

NVO:

DKK 268.30B

EBITDA (TTM)

NBIS:

-$52.78M

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NBIS vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBIS
NBIS Risk / Return Rank: 9595
Overall Rank
NBIS Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
NBIS Sortino Ratio Rank: 9494
Sortino Ratio Rank
NBIS Omega Ratio Rank: 9191
Omega Ratio Rank
NBIS Calmar Ratio Rank: 9797
Calmar Ratio Rank
NBIS Martin Ratio Rank: 9595
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 3030
Overall Rank
NVO Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 2929
Sortino Ratio Rank
NVO Omega Ratio Rank: 2828
Omega Ratio Rank
NVO Calmar Ratio Rank: 3131
Calmar Ratio Rank
NVO Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBIS vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nebius Group N.V. (NBIS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NBISNVODifference
Sharpe ratioReturn per unit of total volatility

+3.32

Sortino ratioReturn per unit of downside risk

+3.56

Omega ratioGain probability vs. loss probability

1.38

0.97

+0.41

Calmar ratioReturn relative to maximum drawdown

6.96

-0.42

+7.38

Martin ratioReturn relative to average drawdown

15.13

-0.64

+15.77

NBIS vs. NVO - Sharpe Ratio Comparison

The current NBIS Sharpe Ratio is 2.93, which is higher than the NVO Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of NBIS and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NBIS vs. NVO - Drawdown Comparison

The maximum NBIS drawdown since its inception was -58.27%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for NBIS and NVO.


Loading charts...

Drawdown Indicators


NBISNVODifference

Max Drawdown

Largest peak-to-trough decline

-58.27%

-74.70%

+16.43%

Max Drawdown (1Y)

Largest decline over 1 year

-45.47%

-49.17%

+3.70%

Max Drawdown (3Y)

Largest decline over 3 years

-74.70%

Max Drawdown (5Y)

Largest decline over 5 years

-74.70%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

Current Drawdown

Current decline from peak

-24.34%

-64.12%

+39.78%

Average Drawdown

Average peak-to-trough decline

-18.91%

-17.89%

-1.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.88%

31.80%

-10.92%

Volatility

NBIS vs. NVO - Volatility Comparison

Nebius Group N.V. (NBIS) has a higher volatility of 37.73% compared to Novo Nordisk A/S (NVO) at 9.44%. This indicates that NBIS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NBISNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

37.73%

9.44%

+28.29%

Volatility (6M)

Calculated over the trailing 6-month period

77.62%

36.36%

+41.26%

Volatility (1Y)

Calculated over the trailing 1-year period

108.22%

51.69%

+56.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.13%

38.57%

+72.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.13%

32.63%

+78.50%

Dividends

NBIS vs. NVO - Dividend Comparison

NBIS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.65%.


PositionTTM20252024202320222021202020192018201720162015
NBIS
Nebius Group N.V.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
3.65%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

NBIS vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Nebius Group N.V. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
399.00M
96.82B
(NBIS) Total Revenue
(NVO) Total Revenue
Please note, different currencies. NBIS values in USD, NVO values in DKK

Frequently Asked Questions


NBIS and NVO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NBIS has higher volatility (37.73%) compared to NVO (9.44%). In terms of maximum drawdown, NBIS dropped -58.27% vs NVO's -74.70%.

NBIS currently has the higher Sharpe Ratio (2.93 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NBIS and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer